CHF86.35
0.92% yesterday
SIX Swiss Exchange, Aug 05, 05:30 pm CET
ISIN
CH0360674466
Symbol
GALE

Galenica Stock price

CHF86.35
-2.55 2.87% 1M
+3.90 4.73% 6M
+12.00 16.14% YTD
+11.80 15.83% 1Y
+12.30 16.61% 3Y
+22.20 34.61% 5Y
+43.35 100.81% 10Y
+43.35 100.81% 20Y
SIX Swiss Exchange, Closing price Tue, Aug 05 2025
-0.80 0.92%
ISIN
CH0360674466
Symbol
GALE

Key metrics

Basic
Market capitalization
CHF4.3b
Enterprise Value
CHF5.0b
Net debt
CHF704.3m
Cash
CHF129.7m
Shares outstanding
49.8m
Valuation (TTM | estimate)
P/E
23.7 | 23.5
P/S
1.1 | 1.0
EV/Sales
1.3 | 1.2
EV/FCF
25.9
P/B
2.8
Dividends
DPS
CHF2.30
Yield 1Y | 5Y
2.6% | 3.1%
Growth 1Y | 5Y
4.5% | 5.0%
Payout 1Y | 3Y
62.7% | 52.8%
Increased
1 Year
Financials (TTM | estimate)
Revenue
CHF3.9b | CHF4.2b
EBITDA
CHF317.9m | CHF337.2m
EBIT
CHF208.2m | CHF230.4m
Net Income
CHF183.0m | CHF184.8m
Free Cash Flow
CHF192.3m
Growth (TTM | estimate)
Revenue
4.7% | 6.9%
EBITDA
7.7% | 7.2%
EBIT
8.2% | 12.5%
Net Income
-35.9% | 1.0%
Free Cash Flow
28.8%
Margin (TTM | estimate)
Gross
27.5%
EBITDA
8.1% | 8.0%
EBIT
5.3%
Net
4.7% | 4.4%
Free Cash Flow
4.9%
Financial Health
Equity Ratio
50.4%
Return on Equity
11.8%
ROCE
8.9%
ROIC
7.3%
Debt/Equity
0.5
More
EPS
CHF3.7
FCF per Share
CHF3.9
Short interest
-
Employees
6k
Rev per Employee
CHF630.0k
Show more

Is Galenica a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,032 stocks worldwide.

Galenica Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Galenica forecast:

6x Buy
50%
6x Hold
50%

Analyst Opinions

12 Analysts have issued a Galenica forecast:

Buy
50%
Hold
50%

Financial data from Galenica

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
3,921 3,921
5% 5%
100%
- Direct Costs 2,843 2,843
5% 5%
73%
1,078 1,078
4% 4%
27%
- Selling and Administrative Expenses 583 583
6% 6%
15%
- Research and Development Expense - -
-
-
318 318
8% 8%
8%
- Depreciation and Amortization 110 110
7% 7%
3%
EBIT (Operating Income) EBIT 208 208
8% 8%
5%
Net Profit 183 183
36% 36%
5%

In millions CHF.

Don't miss a Thing! We will send you all news about Galenica directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Galenica Stock News

marktEINBLICKE
28 days ago
Galenica verstärkt sich mit der Labor Team Group und forciert den Ausbau digitaler Gesundheitslösungen. Anleger dürfen auf neue Impulse hoffen.
AD HOC NEWS
about one month ago
Galenica AG / CH0360674466
AD HOC NEWS
about one month ago
Galenica AG / CH0360674466
More Galenica News

Company Profile

Galenica AG engages as a health care provider in Switzerland. It operates through the following segments: Health & Beauty and Services. The Health and Beauty segment comprises the two business sectors Retail; and Products and Brands. The Services segment offers pharmaceutical and healthcare companies pre-wholesale services, from storage and distribution of products in Switzerland to debt collection. The company was founded on 1927 and is headquartered in Bern, Switzerland.

Head office Switzerland
CEO Marc Werner
Employees 6,241
Founded 1927
Website www.galenica.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today